Friday, May 12, 2023 10:15 AM – 12:15 PM ET Room 204ABC
Block Symposium
Non-immune Therapy in Cancer
Chairs
- Arya Biragyn, NIA, NIH
- Rana Herro, Cincinnati Children’s Hosp. Med. Ctr.
Speakers
- Jiandong Huang, The Univ. of Hong Kong, Attenuated Salmonella blocks cancer metastasis by activating NK cells in an IFN-γ-dependent manner
- Kaiting Yang, Univ. of Chicago, Zinc-c-di-AMP nanoparticles target and suppress tumors via endothelial STING activation and tumor associated macrophage reinvigoration
- Jugal Kishore Das, Texas A&M Univ. Hlth. Sci. Ctr., Engineered live attenuated bacteria producing 5-hydroxyindole remodels heterogeneous tumor microenvironment and promotes antitumor immunity
- Soha M. Kazmi, NIAID, NIH, Global inhibition of Ly-49/MHC-I interactions by anti-MHC-I augments innate and adaptive immunity against cancer metastasis
- Lei Wang, Univ. of Florida Col. of Med., Proteolysis-targeting chimera against NR4A1 for cancer immunotherapy
- Sharmila Nair, Univ. of Louisville, Advancing Immunovirotherapy with Zika virus to treat high-grade brain tumors
- Raziye Piranlioglu, Brigham and Women's Hosp. and Harvard Med. Sch., Assessment of the impact of oncolytic virotherapy on the immunopeptidome profile of tumor by utilizing GEMM derived immunocompetent GBM models
- Sevasti Karaliota, Frederick Natl. Lab. for Cancer Res., Synergy of heterodimeric IL-15 immunotherapy and a fatty acid metabolism modulator enhances intratumoral lymphocyte metabolism and eradicates EO771 murine breast tumors
